Press releases in 2000

21. 12. 2000 |
Ljubljana, 21 December – In this New-Year time, the pharmaceutical company Lek d.d. wishes to bring joy to the children who are the most deprived in this time of the ...
7. 12. 2000 |
Ljubljana, 7 December – Lek’s Supervisory Board has decided to call a Shareholder’s Meeting which will take place on 8th January, 2001 at Lek’s Head Office.
13. 11. 2000 |
Ljubljana, November 13 – The Slovenian pharmaceutical company, Lek, is today introducing a new product, a medicine which provides relief from cold and flu symptoms without causing stomach upset. Lekadol ...
28. 10. 2000 |
Ljubljana, 28 October – Lek Pharmaceutical and Chemical Company d.d. is pleased to announce the appointment of SG, the investment banking arm of the Societe Generale Group, to act as ...
9. 10. 2000 |
Lendava, 9 October – At the presence of representatives from the Ministry of Environment and Spacial Planning and Municipality councilors, Jože Kocon, the Mayor of the Lendava Municipality, and Metod ...
5. 10. 2000 |
Ljubljana, 5 October – In the beginning of September, the Slovene pharmaceutical company Lek adopted a decision on the co-operation with the expert medical portal Jupsline, thereby enabling, as the ...
25. 9. 2000 |
Ljubljana, 25 September – Today, Mrs. Viktorija Potočnik, the Mayor of the Ljubljana City Municipality, laid the foundation stone for the new Lek’s development centre in the presence of representatives ...
11. 9. 2000 |
Lendava, 11 September – The US ambassador in Slovenia, her Excellency Nancy Ely Raphel, visited today, together with the US commercial attaché in Slovenia Trevor J. Evans, the Lendava production ...
29. 8. 2000 |
Ljubljana, 29 August ? In the first half-year of 2000, Lek realized sales to the amount of SIT27.5 billion, which is a 13.2% growth compared to the same period last ...
23. 8. 2000 |
Ljubljana, 23 August – Upon the expiration of a 6-months’ exclusive pediatric right for enalapril, the Slovene pharmaceutical company Lek obtained a registration certificate for this drug in the USA. ...
26. 7. 2000 |
Lek Supervisory Board gives consent to the project of construction of a purifying plant in Lendava Ljubljana, 25 July – At its 19th meeting, Lek Supervisory Board appointed today Jože ...
19. 7. 2000 |
Ljubljana, 19 July – Today, Andrej Bručan, the Slovene Minister of Health, made an official visit with his colleagues to the Slovene Pharmaceutical and Chemical Company Lek d.d. With Lek ...
4. 7. 2000 |
Ljubljana, 4 July – At the premises of Lek d.d., Pharmaceutical and Chemical Company, the 12th Annual General Meeting was held today. The shareholders supported with the majority of votes ...
21. 6. 2000 |
Ljubljana, 21 June – The Slovene pharmaceutical company Lek d.d. is one of the first pharmaceutical companies of the Central and Eastern Europe to have started marketing its finished pharmaceutical ...
20. 6. 2000 |
Riga, 20 June -Today, Lek opened its new representative office in Riga, Latvia. This is one of the representative offices in the Baltic states, representing Lek’s 25th unit abroad. The ...
14. 6. 2000 |
Ljubljana, 13 June – Lek realized sales of SIT 14 billion in the first quarter of the present year, thereby exceeding sales objectives set for this period and achieving 13% ...
15. 5. 2000 |
Skopje, 15 May – Lek, a Slovene pharmaceutical company, opened today a new business centre for the South-Eastern Europe in Skopje, Macedonia. This is one of Lek’s recent major investments. ...
11. 5. 2000 |
Ljubljana, 11 May – The American Food and Drug Administration approved that Slovene pharmaceutical company re-launch the generic drug cimetidine on the US market.
21. 3. 2000 |
Ljubljana, 21 March – Lek d.d. and the Japanese company Fujimoto Pharmaceutical Corporation have settled their dispute with the companies SmithKline & French Laboratories, Ltd., and SmithKline Beecham Seiyaku KK ...
8. 3. 2000 |
Ljubljana, 7 March – On the Women’s Day 2000 the women members of Lek’s Trade Union renounced the symbolical presents given every year, and they agreed to offer the funds ...
2. 3. 2000 |
Ljubljana, 2 March – Despite tougher business conditions on its key markets, the Slovene pharmaceutical company Lek brought the 1999 business year to a successful conclusion, and results exceeded their ...
28. 1. 2000 |
Ljubljana, 27 January – At its meeting of 27 January 2000, the Supervisory Board of Lek Pharmaceutical Company adopted a proposal made by Metod Dragonja, President of Lek Board of ...
19. 1. 2000 |
Ljubljana, 18 January – In the following days Sanofi-Synthelabo-Lek joint venture, recently founded by the French pharmaceutical company Sanofi-Synthelabo and Lek, is starting to operate . The new company will ...
14. 1. 2000 |
Sales growth highest in Poland and Slovenia – Outstanding international sales growth of Lek top product Amoksiklav – Breakthrough of Amoksiklav on the EU markets in 2000 Ljubljana, 14 January ...